Kramer D L, Khomutov R M, Bukin Y V, Khomutov A R, Porter C W
Grace Cancer Drug Center, Roswell Park Memorial Institute, Buffalo, NY 14263.
Biochem J. 1989 Apr 15;259(2):325-31. doi: 10.1042/bj2590325.
S-(5'-Deoxy-5'-adenosyl)methylthioethylhydroxylamine (AMA) is an irreversible inhibitor of S-adenosylmethionine (AdoMet) decarboxylase, which is designed to bind covalently the pyruvate residue at the enzyme active site. In the present study the cellular effects of AMA were characterized for the first time in cultured L1210 leukaemia cells. At the approximate IC50 (concn. giving 50% inhibition; 100 microM), AMA decreased spermidine and spermine by more than 80% at 48 h while increasing putrescine more than 10-fold. As an indication of enzyme specificity, growth inhibition was fully prevented with exogenous spermidine. When compared with the irreversible inhibitor of ornithine decarboxylase, alpha-difluoromethylornithine (DFMO), at similar growth-inhibitory concentrations, AMA was less cytotoxic, as determined by colony-formation efficiency. In combination with AMA, DFMO eliminated the rise in putrescine and decreased growth in an additive manner. The near-total depletion of intracellular polyamine pools achieved with the drug combination provided an opportunity to examine the relative abilities of individual polyamines to support growth and viability. Of the three exogenously supplied polyamines, only spermidine fully sustained cell growth and viability at control values during incubations totalling 120 h. By contrast, spermine supported growth at 23% of control and viability at 8%. Putrescine was similarly ineffective, supporting growth at 13% of control and viability at 7%. The data indicate that, in L1210 cells, spermidine is apparently the preferred polyamine in growth-related functions and is capable of fully supporting cell growth by itself. However, because spermine and putrescine can also support growth to some extent, maximum interference with growth and viability is best achieved by strategies which deplete all three polyamine pools.
S-(5'-脱氧-5'-腺苷基)甲硫基乙羟胺(AMA)是S-腺苷甲硫氨酸(AdoMet)脱羧酶的不可逆抑制剂,其设计用于与酶活性位点的丙酮酸残基共价结合。在本研究中,首次在培养的L1210白血病细胞中表征了AMA的细胞效应。在大约IC50(产生50%抑制的浓度;100微摩尔)时,AMA在48小时内使亚精胺和精胺减少超过80%,同时使腐胺增加超过10倍。作为酶特异性的指标,外源性亚精胺可完全防止生长抑制。与鸟氨酸脱羧酶的不可逆抑制剂α-二氟甲基鸟氨酸(DFMO)相比,在相似的生长抑制浓度下,通过集落形成效率测定,AMA的细胞毒性较小。与AMA联合使用时,DFMO消除了腐胺的升高并以相加方式降低生长。药物组合实现的细胞内多胺池几乎完全耗尽提供了一个机会来检查单个多胺支持生长和活力的相对能力。在三种外源性提供的多胺中,在总共120小时的孵育期间,只有亚精胺能使细胞生长和活力完全维持在对照值。相比之下,精胺支持的生长为对照的23%,活力为8%。腐胺同样无效,支持的生长为对照的13%,活力为7%。数据表明,在L1210细胞中,亚精胺显然是生长相关功能中首选的多胺,并且能够自身完全支持细胞生长。然而,由于精胺和腐胺也能在一定程度上支持生长,通过耗尽所有三个多胺池的策略能最好地实现对生长和活力的最大干扰。